GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 114
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GC1F10E4AE5EN
Leaflet:

Download PDF Leaflet

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
Summary

GlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabolic and urological diseases, immuno-inflammation and cancer, among others. The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders. Its vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company operates research facilities in France, Germany, the UK, Belgium, Spain, the US, Canada, and China. Its operations span Asia and the Middle East, Australasia, North America, South and Central America, and Europe. GSK is headquartered in Middlesex, the UK.

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deal Details
Venture Financing
Progyny Raises Additional Funds through Venture Financing
ZappRx Raises USD5.6 Million in Series A Financing
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing
ZappRx Raises US$2 Million In Seed Financing
Health XL Raises Funds Through Venture Financing
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing
SR One Plans To Invest In Biotechnology Company
IlluminOss Medical Raises US$28 Million In Series C Financing
Auxogyn Raises US$18 Million In Series B Financing
SpringLeaf Therapeutics Secures Additional US$4 Million In Series B Financing
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round
Semprus BioSciences Secures US$18 Million In Series B Financing
Partnerships
GlaxoSmithKline Enters Into An Agreement With Labtec
Response Genetics Signs Licensing Agreement With GlaxoSmithKline
GlaxoSmithKline May Form Joint Venture with Qualcomm
Propeller Health Enters into R&D Agreement with GlaxoSmithKline
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK
Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare
Abbott Labs Expands Its Co-Development Agreement With GlaxoSmithKline Biologicals
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals
Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline
Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture
Insulet Enters Into Distribution Agreement With GlaxoSmithKline
bioMerieux Signs Co-Development Agreement With GlaxoSmithKline
Abbott Labs Enters Into An Agreement With GlaxoSmithKline
Equity Offering
Response Genetics Completes Private Placement Of Shares For US$9 Million
Asset Transactions
Sinclair IS Pharma Acquires Atlean From Stiefel Labs
Acquisition
Teleflex Acquires Semprus BioSciences For Up To US$80 Million
Phadia To Acquire Nanjing Wei Kang From Nanjing MeiRui
GlaxoSmithKline Plc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Apr 18, 2016: GSK opens new state of the art respiratory manufacturing facility in Ware, UK
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery
Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund
Nov 03, 2015: GSK profiles innovative R&D portfolio to investors
Financial Announcements
Apr 27, 2016: GSK Announces First quarter 2016
Feb 03, 2016: GSK Announces Full year and Fourth Quarter 2015 Results
Jul 29, 2015: GSK: Results Announcement for the second quarter 2015
Corporate Communications
Jun 14, 2016: GlaxoSmithKline: Executive Director Change
May 27, 2016: GlaxoSmithKline Announces Board and Committee changes
Mar 17, 2016: Sir Andrew Witty to retire from GSK in March 2017
Mar 17, 2016: GlaxoSmithKline: Directorate changes
Legal and Regulatory
Jan 20, 2016: Scientists Indicted For Allegedly Stealing Biopharmaceutical Trade Secrets
Product News
Mar 07, 2016: New Health Outcomes Data Reinforce Role of Device Selection and Peak Inspiratory Flow Rate in Treatment of COPD Patients
Other Significant Developments
Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award
Mar 31, 2016: GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries
Mar 04, 2016: GSK names winners of 2015 Discovery Fast Track Challenge
Aug 17, 2015: Operations resume in Zebulon, NC
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GlaxoSmithKline Plc, Medical Equipment, Key Facts, 2015
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016
GlaxoSmithKline Plc, Deals By Market, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2010 to YTD 2016
Progyny Raises Additional Funds through Venture Financing
ZappRx Raises USD5.6 Million in Series A Financing
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing
ZappRx Raises US$2 Million In Seed Financing
Health XL Raises Funds Through Venture Financing
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing
SR One Plans To Invest In Biotechnology Company
IlluminOss Medical Raises US$28 Million In Series C Financing
Auxogyn Raises US$18 Million In Series B Financing
SpringLeaf Therapeutics Secures Additional US$4 Million In Series B Financing
High Throughput Genomics Secures US$0.5 Million In Second Closing Of Series D Venture Round
Semprus BioSciences Secures US$18 Million In Series B Financing
GlaxoSmithKline Enters Into An Agreement With Labtec
Response Genetics Signs Licensing Agreement With GlaxoSmithKline
GlaxoSmithKline May Form Joint Venture with Qualcomm
Propeller Health Enters into R&D Agreement with GlaxoSmithKline
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK
Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare
Abbott Labs Expands Its Co-Development Agreement With GlaxoSmithKline Biologicals
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals
Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline
Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture
Insulet Enters Into Distribution Agreement With GlaxoSmithKline
bioMerieux Signs Co-Development Agreement With GlaxoSmithKline
Abbott Labs Enters Into An Agreement With GlaxoSmithKline
Response Genetics Completes Private Placement Of Shares For US$9 Million
Sinclair IS Pharma Acquires Atlean From Stiefel Labs
Teleflex Acquires Semprus BioSciences For Up To US$80 Million
Phadia To Acquire Nanjing Wei Kang From Nanjing MeiRui
GlaxoSmithKline Plc, Key Competitors
GlaxoSmithKline Plc, Key Employees
GlaxoSmithKline Plc, Other Locations
GlaxoSmithKline Plc, Subsidiaries

LIST OF FIGURES

GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2010 to YTD 2016
GlaxoSmithKline Plc, Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: